Mackenzie Financial Corp Has $1.35 Million Stock Holdings in Xylem Inc. (NYSE:XYL)

Mackenzie Financial Corp increased its position in Xylem Inc. (NYSE:XYL) by 42.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,946 shares of the industrial products company’s stock after buying an additional 3,265 shares during the period. Mackenzie Financial Corp’s holdings in Xylem were worth $1,354,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of XYL. American Century Companies Inc. grew its stake in shares of Xylem by 19.1% in the 2nd quarter. American Century Companies Inc. now owns 6,017 shares of the industrial products company’s stock valued at $722,000 after buying an additional 966 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in Xylem by 13.2% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 33,419 shares of the industrial products company’s stock valued at $4,009,000 after purchasing an additional 3,899 shares during the last quarter. O Shaughnessy Asset Management LLC boosted its stake in Xylem by 49.2% during the 2nd quarter. O Shaughnessy Asset Management LLC now owns 795 shares of the industrial products company’s stock valued at $95,000 after purchasing an additional 262 shares during the last quarter. Rafferty Asset Management LLC boosted its stake in Xylem by 18.5% during the 2nd quarter. Rafferty Asset Management LLC now owns 4,031 shares of the industrial products company’s stock valued at $484,000 after purchasing an additional 628 shares during the last quarter. Finally, Atria Investments LLC boosted its stake in Xylem by 27.7% during the 2nd quarter. Atria Investments LLC now owns 17,116 shares of the industrial products company’s stock valued at $2,053,000 after purchasing an additional 3,711 shares during the last quarter. Institutional investors own 83.84% of the company’s stock.

A number of research firms have issued reports on XYL. Credit Suisse Group lifted their price target on Xylem from $105.00 to $111.00 and gave the company an “underperform” rating in a research note on Wednesday, November 3rd. Royal Bank of Canada cut their price target on Xylem from $140.00 to $136.00 and set an “outperform” rating for the company in a research note on Friday, October 1st. Raymond James downgraded Xylem from a “market perform” rating to an “underperform” rating in a research note on Tuesday, January 4th. Loop Capital assumed coverage on shares of Xylem in a research report on Monday, November 22nd. They set a “hold” rating and a $120.00 target price on the stock. Finally, Mizuho assumed coverage on shares of Xylem in a research report on Thursday, December 16th. They set a “neutral” rating and a $115.00 target price on the stock. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $122.30.

In other news, SVP Matthew Francis Pine sold 2,000 shares of the stock in a transaction that occurred on Wednesday, December 1st. The shares were sold at an average price of $121.32, for a total transaction of $242,640.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Patrick Decker sold 54,643 shares of the stock in a transaction that occurred on Tuesday, November 9th. The shares were sold at an average price of $132.91, for a total transaction of $7,262,601.13. The disclosure for this sale can be found here. Insiders sold a total of 64,238 shares of company stock worth $8,470,296 in the last ninety days. 0.90% of the stock is currently owned by insiders.

NYSE:XYL opened at $111.54 on Friday. The company has a current ratio of 2.33, a quick ratio of 1.81 and a debt-to-equity ratio of 0.79. The stock has a market capitalization of $20.11 billion, a PE ratio of 43.74, a price-to-earnings-growth ratio of 3.26 and a beta of 1.03. The firm’s 50 day moving average is $121.63 and its 200 day moving average is $125.52. Xylem Inc. has a 12 month low of $94.63 and a 12 month high of $138.78.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, November 2nd. The industrial products company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. The company had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.28 billion. Xylem had a net margin of 8.81% and a return on equity of 15.97%. During the same quarter in the previous year, the firm posted $0.62 EPS. Research analysts predict that Xylem Inc. will post 2.48 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 21st. Investors of record on Tuesday, November 23rd were issued a $0.28 dividend. The ex-dividend date of this dividend was Monday, November 22nd. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.00%. Xylem’s dividend payout ratio (DPR) is presently 43.92%.

Xylem Company Profile

Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.

Featured Article: CBOE Russell 2000® Volatility Index

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.